Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIEN™ 3 TAVR Valves: A Single-Center Experience.
bmi
permanent pacemaker
transcatheter aortic valve replacement (tavr)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
15 Jul 2019
15 Jul 2019
Historique:
entrez:
23
7
2019
pubmed:
23
7
2019
medline:
23
7
2019
Statut:
epublish
Résumé
Transcatheter aortic valve replacement (TAVR) can be complicated with a high-degree atrioventricular block requiring a permanent pacemaker (PPM) in 5% - 25% of patients. Association between body mass index (BMI) and pacemaker implantation has not been extensively studied. We compared standard BMI classes with the odds of requiring a PPM implantation in patients undergoing TAVR with Edwards SAPIEN™ 3 valves (ESV3) (Edwards Lifesciences, Irvine, CA, USA). Our study involved a single-center retrospective cohort analysis of 449 patients undergoing TAVR from December 2012 to April 2018. First, we excluded patients with a TAVR procedure done with valves other than the ESV3 (127 patients). Second, patients with a prior PPM or an implantable cardioverter-defibrillator (37 patients) were excluded. Finally, patients with an aborted procedure and surgical conversion were excluded (16 patients). The final sample size was 269. The primary outcome was pacemaker implantation. Statistical analysis was done using the Chi-square test, T-test, and adjusted logistic regression. Of the 269 patients (50.6% males; mean age of 79.5 ± 8.7 years; mean Society of Thoracic Surgeons (STS) score: 6.2), pacemaker implantation was performed in 17 patients (6.3%). Time to pacemaker implantation was 1.3 days. Patients were divided into four categories based on their BMI: as underweight (BMI < 25; 67 patients), normal (BMI: 25 to ≤ 30; 87 patients), overweight (BMI: 30 to ≤ 35; 60 patients), and obese (BMI ≥ 35; 55 patients). Pacemaker implantation was significantly higher in patients with a BMI of > 30 (13 vs. 4, p = 0.037). After logistic linear regression, the odds of getting a PPM after TAVR were significantly higher in patients who were overweight (odds ratio (OR): 12.77, p = 0.024; confidence interval (CI): 1.39 - 17.25) and obese (OR: 15.02, p = 0.036, CI: 1.19 - 19.92). Our study demonstrates that increased BMI is a possible risk factor for a high-degree atrioventricular block in patients receiving ESV3.
Sections du résumé
BACKGROUND
BACKGROUND
Transcatheter aortic valve replacement (TAVR) can be complicated with a high-degree atrioventricular block requiring a permanent pacemaker (PPM) in 5% - 25% of patients. Association between body mass index (BMI) and pacemaker implantation has not been extensively studied. We compared standard BMI classes with the odds of requiring a PPM implantation in patients undergoing TAVR with Edwards SAPIEN™ 3 valves (ESV3) (Edwards Lifesciences, Irvine, CA, USA).
METHODS
METHODS
Our study involved a single-center retrospective cohort analysis of 449 patients undergoing TAVR from December 2012 to April 2018. First, we excluded patients with a TAVR procedure done with valves other than the ESV3 (127 patients). Second, patients with a prior PPM or an implantable cardioverter-defibrillator (37 patients) were excluded. Finally, patients with an aborted procedure and surgical conversion were excluded (16 patients). The final sample size was 269. The primary outcome was pacemaker implantation. Statistical analysis was done using the Chi-square test, T-test, and adjusted logistic regression.
RESULTS
RESULTS
Of the 269 patients (50.6% males; mean age of 79.5 ± 8.7 years; mean Society of Thoracic Surgeons (STS) score: 6.2), pacemaker implantation was performed in 17 patients (6.3%). Time to pacemaker implantation was 1.3 days. Patients were divided into four categories based on their BMI: as underweight (BMI < 25; 67 patients), normal (BMI: 25 to ≤ 30; 87 patients), overweight (BMI: 30 to ≤ 35; 60 patients), and obese (BMI ≥ 35; 55 patients). Pacemaker implantation was significantly higher in patients with a BMI of > 30 (13 vs. 4, p = 0.037). After logistic linear regression, the odds of getting a PPM after TAVR were significantly higher in patients who were overweight (odds ratio (OR): 12.77, p = 0.024; confidence interval (CI): 1.39 - 17.25) and obese (OR: 15.02, p = 0.036, CI: 1.19 - 19.92).
CONCLUSIONS
CONCLUSIONS
Our study demonstrates that increased BMI is a possible risk factor for a high-degree atrioventricular block in patients receiving ESV3.
Identifiants
pubmed: 31328076
doi: 10.7759/cureus.5142
pmc: PMC6634273
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e5142Déclaration de conflit d'intérêts
The authors have declared financial relationships, which are detailed in the next section.
Références
Am J Med Sci. 2001 Apr;321(4):225-36
pubmed: 11307864
Circulation. 2006 Feb 14;113(6):898-918
pubmed: 16380542
JACC Cardiovasc Interv. 2008 Jun;1(3):305-9
pubmed: 19463318
Circulation. 2009 Aug 4;120(5):e29-30
pubmed: 19652115
Am Heart J. 2012 Mar;163(3):492-9
pubmed: 22424022
JACC Cardiovasc Interv. 2012 May;5(5):533-539
pubmed: 22625192
Am J Cardiol. 2012 Oct 15;110(8):1156-63
pubmed: 23021601
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E569-77
pubmed: 23475694
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716
Am J Cardiol. 2015 Jan 15;115(2):227-33
pubmed: 25534764
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9
pubmed: 25616819
JACC Cardiovasc Interv. 2016 Feb 8;9(3):244-254
pubmed: 26847116
J Am Coll Cardiol. 2016 Jun 7;67(22):2565-74
pubmed: 27050187
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2189-2199
pubmed: 27832844
Am J Cardiol. 2017 Jan 15;119(2):308-316
pubmed: 27839771
Ann Thorac Surg. 2017 Mar;103(3):1021-1035
pubmed: 27955994
Neth Heart J. 2017 Sep;25(9):498-509
pubmed: 28536936